Mark N. Wegman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 12,000 shares at $64.04 ($768K) on 2019-05-21, disclosed to the SEC on 2019-05-22.
Open-market sale of $768k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.04 | 6,000 | $384K | 50.0% |
| 2 | $64.04 | 6,000 | $384K | 50.0% |
| Total | $64.04 avg | 12,000 | $768K | 100% |
| Filing → |
| BSTC | SELL | 2018-09-11 | $374K | — | Filing → |
| BSTC | SELL | 2018-08-23 | $895K | — | Filing → |